We don't know whether the most recent response to this request contains information or not – if you are Stefan Clausing please sign in and let everyone know.

All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors

Stefan Clausing made this Official Information request to Pharmaceutical Management Agency

This request has an unknown status. We're waiting for Stefan Clausing to read recent responses and update the status.

From: Stefan Clausing

Dear Pharmaceutical Management Agency,

Can I please request all communications (emails and chat messages) that mention continuous glucose monitors (e.g. Dexcom, FreeStyle Libre) sent in 2022 either to Ministers or their offices, or that discuss contact with Ministers or their offices, from the Chief Executive, Director of Operations and Pharmac communications staff.

Yours faithfully,
Stefan

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment 2022 23 105 2023 03 23 Response Letter.pdf
126K Download View as HTML

Attachment 2022 11 25 Henare briefing.pdf
932K Download View as HTML

Attachment 2022 09 28 Briefing Minister Henare for quarterly meeting.pdf
97K Download View as HTML


Kia ora Stefan,

Please find a response to your request attached to this email.

Kind regards,

Gendi McFadyen| Government Services Advisor
Te Pātaka Whaioranga | Pharmac
PO Box 10-254, Wellington 6140 | Level 9, 40 Mercer Street, Wellington 6011
P: 0800 660 050 | www.pharmac.govt.nz

-----Original Message-----
From: Stefan Clausing <[FOI #21900 email]>
Sent: Thursday, 23 February 2023 3:15 pm
To: Web Enquiry <[email address]>
Subject: Official Information request - All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors

[You don't often get email from [FOI #21900 email]. Learn why this is important at https://aka.ms/LearnAboutSenderIdentific... ]

Dear Pharmaceutical Management Agency,

Can I please request all communications (emails and chat messages) that mention continuous glucose monitors (e.g. Dexcom, FreeStyle Libre) sent in 2022 either to Ministers or their offices, or that discuss contact with Ministers or their offices, from the Chief Executive, Director of Operations and Pharmac communications staff.

Yours faithfully,
Stefan

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #21900 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://aus01.safelinks.protection.outlo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://aus01.safelinks.protection.outlo...

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment 2022 23 105 2023 03 30 Response Letter.pdf
126K Download View as HTML


Kia ora Stefan,

Please find a response to your request attached to this email.

Kind regards

Gendi McFadyen| Government Services Advisor
Te Pātaka Whaioranga | Pharmac
PO Box 10-254, Wellington 6140 | Level 9, 40 Mercer Street, Wellington 6011
P: 0800 660 050 | www.pharmac.govt.nz

-----Original Message-----
From: Web Enquiry
Sent: Thursday, March 23, 2023 1:38 PM
To: 'Stefan Clausing' <[FOI #21900 email]>
Subject: RE: Official Information request - All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors

Kia ora Stefan,

Please find a response to your request attached to this email.

Kind regards,

Gendi McFadyen| Government Services Advisor Te Pātaka Whaioranga | Pharmac PO Box 10-254, Wellington 6140 | Level 9, 40 Mercer Street, Wellington 6011
P: 0800 660 050 | www.pharmac.govt.nz

-----Original Message-----
From: Stefan Clausing <[FOI #21900 email]>
Sent: Thursday, 23 February 2023 3:15 pm
To: Web Enquiry <[email address]>
Subject: Official Information request - All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors

[You don't often get email from [FOI #21900 email]. Learn why this is important at https://aka.ms/LearnAboutSenderIdentific... ]

Dear Pharmaceutical Management Agency,

Can I please request all communications (emails and chat messages) that mention continuous glucose monitors (e.g. Dexcom, FreeStyle Libre) sent in 2022 either to Ministers or their offices, or that discuss contact with Ministers or their offices, from the Chief Executive, Director of Operations and Pharmac communications staff.

Yours faithfully,
Stefan

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #21900 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://aus01.safelinks.protection.outlo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://aus01.safelinks.protection.outlo...

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

We don't know whether the most recent response to this request contains information or not – if you are Stefan Clausing please sign in and let everyone know.

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: